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Abstract	  
	  
Adhesion	  G-­‐protein	  coupled	  receptors	   (aGPCRs)	  are	  the	  second	   largest	   family	  of	  GPCRs,	  with	  33	  
homologues	  in	  humans.	  Despite	  the	  multitude	  of	  roles	  that	  they	  play,	  the	  majority	  of	  them	  are	  still	  
orphans	  and	  the	  signaling	  pathways	  involved	  in	  their	  activations	  barely	  unknown.	  The	  aim	  of	  this	  
study	   is	   to	   investigate	   the	   constitutive	  activity	  of	  different	   truncations	  of	   the	  N-­‐terminus	  of	   the	  
GPR56,	  GPR64	  and	  GPR112	  receptors	  that	  belong	  to	  the	  subfamily	  VIII	  of	  the	  aGPCRs,	  in	  order	  to	  
shed	   light	   on	   their	   downstream	   pathways.	   Modified	   strains	   of	   Saccharomyces	   cerevisiae	   have	  
been	  used	  for	  this	  study.	  These	  strains	  contain	  chimeric	  Gp1a/Gα	  proteins	  that	  are	  able	  to	  couple	  
to	   a	   heterologous	   GPCR	   and	   give	   a	   response	   via	   the	   pheromone-­‐response	   pathway.	   The	  
constitutive	   activity	   has	   been	   evaluated	   as	   the	   growth	   of	   yeast	   cells	   in	   a	   medium	   lacking	   of	  
histidine,	   since	   the	   production	   of	   this	   amino	   acid	   (essential	   for	   S.	   cerevisiae)	   is	   due	   to	   the	  
activation	  of	   the	   receptor.	  During	   the	   initial	   screen	   the	  GPR112-­‐7TM	  and	   the	  GPR112-­‐GPS	  have	  
been	  tested	   in	  all	   the	  strains,	  coupling	  different	  Gα	  proteins;	   this	  was	  necessary	  to	  optimise	  the	  
assay	  in	  itself	  and	  to	  discriminate	  the	  strains	  to	  use	  later.	  In	  the	  following	  part	  of	  the	  study,	  all	  the	  
constructs	  generated	  by	  the	  truncation	  of	  the	  N-­‐termini	  have	  been	  tested	  in	  selected	  yeast	  strains,	  
based	  on	  the	  initial	  screen	  and	  the	  information	  gathered	  in	   literature.	   Intriguingly,	  the	  receptors	  
showed	  different	  responses	  among	  the	  different	  strains	  and	  a	  same	  receptor	  displayed	  a	  different	  
mechanism	  of	  activation	  based	  on	  the	  signaling	  pathway	  involved.	  In	  fact,	  the	  GPR64-­‐ZO1	  seems	  
to	  have	  interactions	  with	  other	  components	  on	  the	  extracellular	  region,	  the	  GPR56	  shows	  a	  higher	  
activity	  when	  the	  N-­‐terminal	  fragment	  is	  cleaved	  out,	  the	  GPR112-­‐GAIN	  (via	  Gα14)	  modulates	  the	  
activity	  of	  the	  receptor,	  which	  is	  fully	  activated	  when	  the	  N-­‐terminus	  is	  removed.	  Moreover,	  the	  
GPR64-­‐ZO1	  modulates	  the	  activity	  of	  the	  receptor	  positively	  via	  Gα14	  but	  negatively	  via	  Gα12,	  the	  
three	  constructs	  of	  the	  GPR112	  show	  the	  same	  level	  of	  activation	  via	  Gα16,	  Gα12	  and	  Gα13,	  but	  
via	  Gα14	  the	  receptor	   is	   fully	  activated	  when	  the	  N-­‐terminus	   is	   removed,	   the	  GPR56-­‐7TM	  has	  a	  




List	  of	  Abbreviation	  
	  
3-­‐AT	   3-­‐amino-­‐[1,2,4]-­‐triazole	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G	  protein-­‐coupled	  receptors	   (GPCRs)	  are	   the	   largest	   family	  of	  cell-­‐surface	   receptors	  with	  almost	  
800	  identified	  genes	  encoding	  them.	  They	  are	  characterized	  by	  a	  bundle	  of	  seven-­‐transmembrane	  
(7TM)	   α-­‐helices	   and	   their	   name	   is	   due	   to	   the	   interaction	   with	   the	   heterotrimeric	   GTP-­‐binding	  
regulatory	   proteins:	   G	   proteins	   (Venkatakrishnan	   et	   al.	   2013),	   consisting	   of	   Gα,	   Gβ,	   and	   Gγ	  
subunits.	  
GPCRs	   can	  be	   classified	  according	   to	   their	  pharmacological	  properties	   into	   four	   families:	   class	  A	  
rhodopsin-­‐like,	   class	   B	   secretin-­‐like,	   class	   C	   metabotropic	   glutamate/pheromone	   and	   frizzled	  
receptors	  (Venkatakrishnan	  et	  al.	  2013)	  or	  into	  five	  families	  according	  to	  the	  GRAFS	  classification,	  
based	   on	   phylogenetic	   studies:	   Glutamate,	   Rhodopsin,	   Adhesion,	   Frizzled/Taste	   2	   and	   Secretin	  
(Lagerström	  et	  al.	  2008).	  
Three	   distinct	   regions	   can	   be	   individuated	   in	   the	   general	   structure	   of	   a	   GPCR:	   the	   extracellular	  
region,	   consisting	   of	   the	   extracellular	  N-­‐terminus	   and	   three	   extracellular	   loops	   (ECL1-­‐ECL3),	   the	  
transmembrane	  (TM)	  region,	  consisting	  of	  seven	  α-­‐helices	  (TM1-­‐TM7)	  and	  the	  intracellular	  region,	  
consisting	  of	  three	  intracellular	  loops	  (ICL1-­‐ICL3),	  an	  amphipathic	  helix	  (H8)	  and	  the	  intracellular	  C-­‐
terminus	  (Venkatakrishnan	  et	  al.	  2013).	  
The	  activation	  of	  the	  receptor	  entails	  the	  exchange	  of	  GDP	  for	  GTP	  at	  the	  GTPase	  domain	  on	  the	  
Gα	  subunit	  and	  consequently,	   the	  dissociation	  of	   the	  Gα	  monomer	  from	  the	  Gβγ	  dimer	  and	  the	  
modulation	  of	   effector	  molecules.	   In	   humans,	   around	   twenty	  Gα,	   six	  Gβ	   and	   ten	  Gγ	  have	  been	  
identified	  (Clementi	  et	  al.	  2004).	  Gα	  subunits	  have	  been	  classified	  into	  four	  different	  families:	  	  Gαs,	  
Gαq,	  Gα12	  and	  Gαi.	  The	  activated	  Gα	  can	  trigger	  different	  intracellular	  signaling	  pathways	  based	  
on	  the	  subtype:	  activation	  of	  RhoGEF	  (via	  Gα12),	  changes	   in	   intracellular	   level	  of	  cAMP	  (via	  Gαs	  
and	  Gαi)	  or	  DAG,	  IP3	  and	  Ca2+	  (via	  Gαq)	  (Heng	  et	  al.	  2013).	  
The	   general	   model	   used	   to	   describe	   the	   activation	   of	   a	   GPCR	   requires	   the	   participation	   of	   a	  
receptor,	  a	  G	  protein	  and	  an	  agonist.	  In	  the	  figure	  1	  there	  is	  an	  example	  of	  the	  multitude	  of	  ligands	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Fig.	   1	  Variety	  of	   ligands	  and	  signaling	  pathways	   involved	   in	   the	  activation	  of	  GPCRs	   (Marinissen	  et	  al.	  2001).	  Amino	  
acids,	   amines,	   ions,	   lipids,	   peptides	   and	   proteins	   can	   bind	   GPCRs	   to	   activate	   G-­‐protein	   pathway.	   These	   pathways	  
regulate	  several	  cellular	  responses,	  for	  instance:	  proliferation,	  differentiation	  and	  cell	  survival.	  
	  
Nevertheless,	  this	  model	  is	  not	  enough	  to	  describe	  the	  complexity	  of	  these	  receptors	  in	  fact,	  many	  
GPCRs	   can	   activate	   G	   proteins	   in	   the	   absence	   of	   agonist	   (Gether	   et	   al.	   1998).	   The	   ability	   of	   a	  






The	  Adhesion	  family	  (class	  B)	  is	  the	  second	  largest	  GPCRs	  family	  in	  humans,	  with	  33	  homologs	  in	  
human	  genome	  (Bjarnadóttir	  et	  al.	  2007;	  Langenhan	  et	  al.	  2013).	  
Adhesion-­‐GPCRs	   play	   several	   roles,	   from	   development	   to	   immunity,	   from	   reproduction	   to	  
tumorigenesis	  and	  also	  epithelial	  and	  neuronal	  functions.	  The	  first	  aGPCR	  that	  has	  been	  found	  to	  
cause	  a	  disorder	  has	  been	  the	  GPR56,	  which	  causes	  a	  disorder	  of	  cerebral	  cortical	  development	  
called	  bilateral	  frontoparietal	  polymicrogyria	  (BFPP)	  (Langenhan	  et	  al.	  2013).	  
Despite	  their	  wide	  diffusion	  and	  their	  different	  roles,	  the	  majority	  of	  the	  adhesion-­‐GPCRs	  are	  still	  
orphans	   and	   the	   signaling	   pathways	   involved	   in	   their	   activation	   barely	   unknown	   (Gupte	   et	   al.	  
2012).	  
Adhesion	  GPCRs	   are	   subclassified	   in	   nine	   distinct	   families	   basing	   on	   the	  molecular	   signature	   of	  




Fig.	  2	  aGPCR	  subfamilies	  (figure	  adapted	  from	  Langenhan	  et	  al.	  2013).	  
	  
	  
The	   features	   of	   these	   receptors	   reside	   in	   their	   N-­‐terminal	   extracellular	   domain:	   a	   large	  
extracellular	  region	  that	  autoproteolytically	  (no	  proteases	  seem	  to	  be	  involved)	  cleaved	  out	  from	  
its	  own	  7TM.	  
The	   proteolysis	   site,	   consisting	   of	   about	   40	   residues,	   is	   called	   GPS	   (GPCR	   proteolysis	   site).	   This	  
motif	  has	  recently	  been	  found	  being	  part	  of	  a	  much	  larger	  domain,	  around	  320	  residues,	  named	  
	   6	  
GAIN	   (GPCR-­‐Autoproteolysis	   INducing)	   domain,	  without	  which	   the	   autoproteolysis	   cannot	   occur	  
(Araç	  et	  al.	  2012).	  
	  
The	  GAIN	  domain	   is	   preserved	   in	   all	   the	   adhesion	  GPCRs	   in	  human	  except	   for	   the	  GPR123	   that	  
does	  not	  have	  an	  extracellular	  region	  at	  all.	  The	  preservation	  of	  this	  domain	  decreases	  from	  its	  C-­‐
terminus	  (the	  GPS	  motif)	  to	  the	  N-­‐terminus	  and	  to	  be	  precise,	   it	   is	  the	  homology	  of	  the	  primary	  
structure	   that	  decreases	  while	   the	   tertiary	   structure	   is	  more	  preserved.	  Hence	   the	  GPS	  motif	   is	  
highly	  conserved	  among	  the	  different	  receptors	  (Prömel	  et	  al.	  2013).	  
The	   meaning	   and	   the	   mechanism	   of	   the	   autoproteolysis	   are	   still	   not	   clear	   although	   several	  
hypotheses	  have	  been	  suggested.	  
According	   to	   her	   research	   on	   latrophilin	   (LAT-­‐1),	   Simon	   Prömel	   from	   the	   University	   of	   Leipzig	  
indicates	   two	   possible	   interactions	   with	   the	   receptor:	   1)	   the	   GAIN	   (including	   the	   GPS)	   domain	  
operates	  as	  a	   tethered	  endogenous	   ligand	  of	   the	  7TM	  domain;	   this	  can	  occur	   in	  a	  homodimeric	  
complex	  of	   two	   receptors.	   2)	   the	  GAIN	  domain	   interacts	  with	   additional	   partners	   to	   generate	   a	  
response	  independently	  from	  the	  7TM	  and	  the	  C	  terminus	  of	  the	  LAT-­‐1	  (Prömel	  et	  al.	  2012).	  
	  
Based	   on	   his	   research,	   Thue	   Schwartz	   from	   University	   of	   Copenhagen,	   who	   has	   been	   studying	  
adhesion-­‐GPCR	  expressed	  on	  enteroendocrine	  cells,	  suggests	  that	  the	  mechanism	  of	  activation	  of	  
these	  receptors	   implies	  that	  the	  full-­‐length	  N-­‐terminus	  acts	  as	  a	  tethered	   inverse	  agonist	   (figure	  
3);	   binding	   the	   7TM	   domain,	   the	   NT	   (N-­‐terminus)	   modulates	   the	   constitutive	   activity	   of	   the	  
receptor,	  without	  which	  would	  be	  very	  high	  (Araç	  et	  al.	  2012).	  
	  
	  
	  	  	   	  
Fig	   3	   In	   the	  model	   proposed	   by	   Thue	   Schwartz	   from	  University	   of	   Copenhagen,	   the	  N-­‐terminal	   fragment	   acts	   as	   a	  
tethered	   inverse	   agoniste.	   Binding	   the	  7TM,	   it	   inhibits	   the	  otherwise	  high	   constitutive	   activity	  of	   the	   receptor.	   The	  
interactions	   of	   a	   ligand	   with	   one	   of	   the	   domains	   of	   this	   region	   triggers	   the	   cleavage	   of	   the	   N-­‐terminal	   fragments	  
partially	  (middle	  panel)	  or	  totally	  (right	  panel)	  and	  the	  fully	  activation	  of	  the	  receptor	  (figure	  from	  Araç	  et	  al.	  2012).	  
	  
Kevin	  Paavola	  and	  his	  group	  also	  found	  that	  the	  truncation	  of	  the	  N-­‐terminus	  in	  the	  GPR56	  results	  
in	   enhanced	   constitutive	   activation	   of	   receptor	   signaling.	   In	   the	   mechanism	   suggested	   for	   the	  
GPR56	   the	   NT	   stays	   non-­‐covalently	   associated	   to	   the	   7TM	   domain	   after	   proteolysis	   but	   the	  
interaction	   with	   a	   secondary	   molecule,	   probably	   another	   NT,	   might	   interrupt	   the	   bonding	   or	  
change	  the	  conformation	  of	  the	  NT.	  This	  enhances	  the	  activity	  of	  the	  receptor	  (Paavola	  et	  al.	  2013).	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In	  conclusion,	  it	  emerges	  that	  there	  is	  no	  general	  rule	  for	  these	  receptors	  but	  several	  hypothesis	  in	  
which	  the	  N-­‐terminus	  plays	  a	  pivotal	  role	  (figure	  4).	  
	  
Fig.	  4	  Possible	  mechanisms	  suggested	  for	  the	  role	  of	  the	  GAIN	  domain.	  (4A)	  The	  GAIN	  domain	  acts	  as	  a	  negative	  
regulator;	  after	  its	  cleavage	  the	  receptor	  is	  activated.	  On	  the	  contrary	  (4B)	  the	  cleavage	  of	  the	  GAIN	  domain	  interrupts	  
the	  signal.	  (4C)	  The	  GAIN	  domain	  interacts	  with	  other	  components	  on	  the	  extracellular	  region	  and	  this	  can	  activate	  or	  
deactivate	  the	  receptor.	  (4D)	  The	  GAIN	  blocks	  the	  binding	  of	  a	  ligand.	  (4E)	  The	  GAIN	  is	  the	  target	  for	  other	  molecules	  
or	  ligand	  that	  modulate	  the	  activity	  of	  the	  receptor	  (Prömel	  et	  al.	  2013).	  
	  
	  
1.3 Saccharomyces	  cerevisiae	  	  
	  
In	   this	   study,	   Saccharomyces	   cerevisiae	   has	   been	   used	   to	   investigate	   three	   different	   adhesion-­‐
GPCRs	  and	  the	  signal	  transduction	  pathways	  involved	  in	  their	  activation.	  
S.	   cerevisiae,	   also	   known	   as	   budding	   yeast,	   is	   a	   powerful	   tool	   for	   high-­‐throughput	   screening	   in	  
biological	  studies.	   It	  presents	  several	  advantages:	   it	   is	  a	  unicellular	  eukaryotic	  organism	  so	  it	  can	  
be	  used	  as	  a	  model	  system	  eukaryotes	  and	  it	  has	  a	  rapid	  growth	  in	  fact,	  the	  doubling	  time	  is	  about	  
90	  minutes	   in	  yeast	  extract	  peptone	  dextrose	   (YPD)	  medium	   (Sherman	  et	  al.	  2002).	  Yeast	  has	  a	  
highly	   versatile	   DNA	   transformation	   system,	   its	  mechanisms	   of	   GPCR	   signaling	   are	   close	   to	   the	  
ones	  in	  mammalian	  cells	  and	  many	  components	  of	  the	  mating-­‐signaling	  pathway	  can	  be	  replaced	  
by	   the	   mammalian	   correspondents.	   Moreover,	   it	   possesses	   two	   endogenous	   GPCR	   signaling	  
systems	  that	  can	  be	  readily	  removed	  in	  order	  to	  eliminate	  the	  background	  and	  analyse	  the	  target	  
receptors	  (Ladds	  et	  al.	  2005;	  Pausch	  et	  al.	  1997).	  
Haploid	  yeast	   cells	   can	  exist	   in	   two	  mating	   type,	   type	  a	   (MATa)	  and	   type	  α	   (MATα);	   the	  mating	  
occurs	  between	  two	  cells	  of	  the	  opposite	  type,	  generating	  the	  diploid	  MATa/MATα.	  Type	  a	  cells	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secrete	  a	  12-­‐residue	  peptide	  called	  a-­‐Factor	  and	  respond	  to	  α-­‐Factor	  while	  type	  α	  cells	  secrete	  a	  
13-­‐residue	  peptide	  called	  α-­‐Factor	  and	  respond	  to	  a-­‐Factor.	  
The	  interaction	  with	  the	  opposite	  type	  originates	  several	  changes	  in	  the	  yeast	  cells,	  as	  the	  arrest	  at	  
the	  G1	  phase	  of	  the	  cell-­‐cycle,	  ending	  with	  the	  fusion	  of	  the	  two	  nuclei	  and	  the	  formation	  of	  the	  
diploid	   cell.	   The	   signaling	   pathway	   involved	   in	   this	   process	   is	   called	   yeast	   mating	   pheromone	  
response	  pathway	  (Bardwell	  et	  al.	  2004)	  and	  the	  pheromone	  receptor	  is	  bound	  to	  a	  heterotrimeric	  
G	  protein	  consisting	  of	  a	  Gα	  (Gpa1p),	  Gβ	  (Ste4p),	  and	  Gγ	  (Ste18p)	  (Price	  et	  al.	  1995).	  The	  coupling	  
of	  a	  heterologous	  GPCR	  to	  the	  pheromone	  response	  pathway	  is	  possible	  because	  of	  the	  similarity	  
between	  the	  mammalian	  and	  yeast	  G	  proteins;	  the	  homology	  between	  the	  Gα	  subunits	  in	  fact,	  is	  
of	  the	  48-­‐65%.	  Other	  modifications	  have	  been	  done	  to	   improve	  this	  tool	  such	  as	  the	  deletion	  of	  
the	   FAR1	   that	   prevents	   the	   cell	   cycle	   arrest	   and	   the	   deletion	   of	   the	   SST2	   that	   sensitizes	   the	  
pheromone	   pathway	   (Dowell	   et	   al.	   2009;	   figure	   5).	   Gβγ	   dimer	   triggers	   the	   mitogen-­‐activated	  
protein	  (MAP)	  kinase	  cascade	  leading	  to	  the	  cell-­‐cycle	  arrest	  mediated	  by	  the	  cycling-­‐dependent	  
kinase	  inhibitor	  Far1p.	  Sst2	  is	  a	  member	  of	  the	  regulators	  of	  G	  proteins	  signaling	  (RGS)	  family.	  It	  is	  
a	   negative	   regulator	   of	   the	  pheromone	   response	  pathway	  by	  direct	   association	  with	  Gpa1	   (Gα)	  
and	  stimulation	  of	  the	  reconversion	  to	  the	  GDP-­‐bound	  state	  (Dohlman	  et	  al.	  1996).	  	  
Heterologous	  GPCRs	  showed	  to	  be	  able	  to	  couple	  to	  the	  yeast	  heterotrimeric	  G	  protein	  (Dowell	  et	  
al.	  2009).	  King	  et	  al.	  has	  been	  the	   first	  who	  reported	  the	  activation	  of	   the	  pheromone-­‐response	  






	  	  	  	  	  Fig.	  5	  Modification	  of	  the	  pheromone-­‐response	  pathway.	  The	  receptors	  are	  coupled	  to	  a	  heterotrimeric	  G	  protein	  
composed	  of	  Gpa1p	  (Gα),	  Ste4p	  (Gβ)	  and	  Ste18p	  (Gγ).	  Gβγ	  signals	  to	  a	  MAP	  kinase	  cascade	  leading	  to	  the	  cell-­‐cycle	  
arrest	  and	  transcription	  of	  mating	  genes.	  Sst2p	  is	  the	  principal	  negative	  regulator	  of	  the	  pathway.	  Successful	  coupling	  
of	  a	  heterologous	  GPCRs	  has	  been	  achieved	  by	  replacing	  Gpa1p	  with	  chimeric	  Gα	  subunits,	  inactivating	  the	  cell-­‐cycle	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1.4 Constructs	  
	  
Enteroendocrine	   cells	   are	   specialized	   epithelial	   cells	   of	   the	   gastrointestinal	   tract	   that	   represent	  
less	  than	  1%	  of	  the	  entire	  gut	  epithelial	  population.	  They	  constitute	  the	  largest	  endocrine	  organ	  in	  
humans,	  producing	  and	  secreting	  a	  multitude	  of	  hormones	  or	  signaling	  molecules	  (Sternini	  et	  al.	  
2008)	   like	   cholecystokinin	   (CCK),	   a	  hormon	  peptide	   secreted	  by	  enteroendocrine	   “I”	   cells	   in	   the	  
proximal	   small	   intestine.	   CCK	   mediates	   gastrointestinal	   feedback	   and	   satiety	   in	   response	   to	  
luminal	  nutrients	   (Liou	  et	  al.	  2011).	  Many	  metabolic	   functions	  are	  regulated	  by	   these	  receptors:	  
pancreatic	  functions,	  appetite,	  gastrointestinal	  motility	  and	  etcetera.	  Several	  orphan	  GPCRs	  have	  
been	  found	   linked	  to	  enteroendocrine	  cells	  and	  assumed	  to	  have	  a	  function	  as	  chemosensors	   in	  
these	  cells	  (Engelstoft	  et	  al.	  2008).	  
	  
Preliminary	   studies	   showed	   that	  enteroendocrine	   cells	   expressing	   cholecystokinin	  display	  higher	  
level	  of	  expression	  of	  certain	  aGPCRs	  than	  the	  neighboring	  cells	  (figure	  6).	  
Different	   truncations	   of	   the	   N-­‐terminus	   of	   the	   GPR112	   have	   been	   tested	   in	   human	   embryonic	  
kidney	   (HEK)	  293	  cells.	  The	  GPR112-­‐WT	  (wild	   type),	   the	  GPR112-­‐GAIN	   (up	  to	   the	  GAIN	  domain),	  
the	  GPR112-­‐GPS	  (GPS	  motif	  entirely	  present)	  and	  GPR112-­‐7TM	  (truncation	  at	  the	  proteolysis	  site).	  




Fig.	  6	  Level	  of	  expression	  of	  certain	  aGPCRs	  in	  enteroendocrine	  cells	  expressing	  cholecystokinin	  GFP-­‐tagged.	  Circled	  in	  
red,	  the	  GPR112	  which	  shows	  a	  high	  expression	  in	  the	  cells	  expressing	  CCK	  and	  the	  GPR56	  and	  GPR64	  that	  belong	  to	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Fig.	  7	  Data	  from	  preliminary	  studies	  in	  HEK293	  cells.	  The	  bar	  graph	  shows	  the	  activity	  of	  the	  GPR112-­‐WT,	  GPR112-­‐7TM,	  
GPR112-­‐GPS	  and	  GPR112-­‐GAIN.	  The	  GPR112-­‐7TM	  displays	  a	  10-­‐fold	  activity	  compared	  to	  the	  WT	  and	  the	  GPR112-­‐GPS	  
a	  5-­‐fold	  activity.	  
	  
	  
From	  the	   figure	  7	  emerges	   the	  high	  expression	  of	   the	  GPR112	  so	  we	  decided	  to	   investigate	   this	  
receptor	   and	   the	   GPR56	   and	   GPR64,	   although	   less	   extended,	   because	   they	   all	   belong	   to	   the	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DNA	  constructs	  (figure	  8)	  have	  been	  prepared	  from	  templates	  by	  using	  the	  proper	  primers	  (table	  
A)	  and	  then	  their	  amount	  has	  been	  amplified	  with	  PCR	  (table	  B).	  The	  reaction	  contained	  primer	  
forward	  and	  primer	  revers	  (250	  ng	  each),	  template	  DNA	  (50	  pg	  –	  1.0	  µg),	  dNTPs	  2	  mM	  (5.0	  µL),	  Pfu	  
DNA	  polymerase	  (1.25-­‐2.50	  U),	  1x	  Pfu	  buffer	  (5.0	  µL)	  and	  MQ	  (up	  to	  50.0	  µL).	  Purification	  has	  been	  
performed	  by	  using	  GFX	  PCR	  DNA	  and	  Gel	  Band	  Purification	  Kit	  (GE	  Healthcare	  Life	  Sciences,	  the	  
Netherlands)	  according	  to	  the	  manual.	  
	  
Tab.	  A	  Generation	  of	  constructs	  
Constructs	   Primer	  forward	   Primer	  revers	   Template	  
GPR56-­‐WT	   CATCATAAGCTTATGACTCCCCAGTCGC	   CATCAGGTCGACTCAGGC
GGGGGCCAC	  
GPR56-­‐WT-­‐1D4	  
GPR56-­‐GAIN	   CATCAGAAGCTTATGGAGGAGAGCCTGGCTCA	   “	   “	  
GPR56-­‐GPS	   ATCAAGCTTATGACTCTGCAATGTGTGTTCTGG	   “	   “	  
GPR56-­‐7TM	   CATCATAAGCTTATGACCTACTTTGCAGTGCTGAT
G	  
“	   “	  





“	   “	  
GPR64-­‐GAIN	   CATCAGGAATTCATGCCTGTGAAAGCCTCATTTTC	   “	   “	  
GPR64-­‐GPS	   CATCAGGAATTCATGACAGTGAGATGTGTATTTT
GGG	  
“	   “	  
GPR64-­‐7TM	   CATCAGGAATTCATGACAAGCTTCGGCGTTCTGC
TG	  
“	   GPR64-­‐GAIN-­‐1D4	  
GPR112-­‐HormB	   CATCATGGATCCATGCTAGAGCCTGGAAATTGCA
AAG	  
“	   GPR112-­‐WT-­‐1D4	  
GPR112-­‐GAIN	   CATCATGGATCCATGCTTCAAGAACTTCCTGACA
AGA	  
“	   GPR112-­‐GAIN-­‐1D4	  
GPR112-­‐GPS	   CATCATGGATCCATGGGAAACCAGAATTATGGTC
AAGT	  
“	   “	  
GPR112-­‐7TM	   CATCATGGATCCATGACCCATTTTGGAGTCTTAAT
GGA	  
“	   “	  
	  
Tab.	  B	  PCR	  information	  
For	  the	  reaction:	   PCR	  apparatus	  settings	   Cycles	  
Template	  50.0	  pg	  –	  1.0	  µg	   	   	  
Primer	  forward	  250	  ng	   1)	  5’	  95°	   	  
Primer	  reverse	  250	  ng	   2)	  45”	  95°	  
30x	  dNTPs	  (2.0	  mM)	  5.0	  µL	   3)	  1’	  50°	  
1x	  Pfu	  buffer	  5.0	  µL	   4)	  6’	  72	  °	  
Pfu	  DNA	  polymerase	  1.25-­‐2.50	  U	   5)	  5’	  72°	   	  
MQ	  33.5	  µL	  (up	  to	  Vf	  =	  50	  µL)	  	   	   	  
	  
After	   the	  digestion	  of	   the	  purified	  DNA	  constructs	  and	  related	  plasmids	   (table	  C),	   the	   fragments	  
were	  ligated	  with	  T4	  DNA	  ligase	  in	  ligase	  buffer	  and	  transformed	  into	  DH5α	  E.	  coli	  competent	  cells	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Tab.	  C	  Digestion.	  
Constructs	   Restriction	  sites	   Buffer	  
GPR56	  constructs	   HindIII/SalI	   2x	  Tango	  
GPR64	  constructs	   EcoRI/XhoI	   “	  
GPR112	  constructs	   BamHI/XhoI	   “	  
	  
Plasmids	  were	  isolated	  from	  bacteria	  with	  QIAprep	  Spin	  Miniprep	  Kit	  (QIAGEN,	  the	  Netherlands).	  	  
The	  sequences	  were	  confirmed	  by	  DNA	  sequencing	  (LGTC,	  Leiden,	  the	  Netherlands).	  
	  
	  
Fig.	  8	  Constructs	  generated	  for	  the	  study.	  
	  
	  
2.2 Transformation	  in	  S.	  cerevisiae	  
	  
Plasmids	  containing	   the	  constructs	  have	  been	  transformed	   into	  different	  strains	  of	  S.	  cerevisiae,	  
expressing	   different	   chimeric	   Gpa1/Gα	   proteins	   (appendix,	   table	   A),	   according	   to	   the	   Lithium-­‐
Acetate	  protocol	  (Gietz	  et	  al.	  1992).	  The	  p426GPD	  (appendix,	  figure	  1)	  has	  been	  used	  in	  this	  study;	  
this	  vector	  has	  a	  strong	  constitutive	  promoter	  that	  enhances	  the	  chances	  to	  express	  the	  non-­‐yeast	  
receptor	  (Mumberg	  et	  al.	  1995;	  Dowell	  et	  al.	  2009).	  
Dr.	  Simon	  Dowell	   (GSK,	  Stevenage,	  UK)	  provided	  the	  strains	  used	  for	  this	  study.	  They	  have	  been	  
obtained	   from	   MMY11	   and	   further	   modified	   in	   order	   to	   investigate	   the	   potential	   interactions	  
between	  the	  mammalian	  GPCRs	  and	  the	  different	  Gα	  subunits.	  
In	   the	   chimeric	   Gpa1p/Gα	   proteins	   the	   last	   five	   amino	   acids	   of	   the	   C	   terminus	   of	   the	   Gpa1p	  
subunit	  are	  substituted	  with	  the	  corresponding	  mammalian	  ones	  (appendix,	  table	  A);	  these	  kind	  of	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substitutions	  allow	  the	  interaction	  with	  the	  heterologous	  receptor	  increasing	  the	  efficiency	  of	  the	  
coupling	  without	  loosing	  the	  affinity	  with	  the	  Gβγ	  dimer	  (Brown	  et	  al.	  2000;	  Dowell	  et	  al.	  2002).	  
The	  pheromone	  signaling	  pathway	  of	   these	   strains	  was	  coupled	  via	   the	  FUS1	  promoter	   to	  HIS3,	  
encoding	   imidazoleglycerol-­‐phosphate	   dehydratase,	   the	   enzyme	   that	   catalyzes	   the	   sixth	   step	   in	  
histidine	   biosynthesis.	   To	   reduce	   the	   latent	   background	   activity,	   3-­‐AT,	   which	   is	   a	   competitive	  
inhibitor	   of	   the	   imidazoleglycerol-­‐phosphate	   dehydratase,	   has	   been	   used	   in	   the	   experiments	  	  
(Dowell	  et	  al.	  2009;	  Liu	  et	  al.	  2014).	  
	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Fig.	   9	  Modified	  Saccharomyces	   cerevisiae.	   The	  MMY	  strains	  have	  been	  modified	   in	  order	   to	  produce	   Leu	  while	   the	  
plasmid,	  p426GPD	  in	  this	  case,	  contains	  the	  information	  to	  produce	  Ura.	  The	  biosynthesis	  of	  His	  is	  correlated	  with	  the	  
activation	  of	  the	  GPCR.	  
	  
	  
2.3 Solid	  growth	  assay	  
	  
The	  constitutive	  activity	  of	  the	  receptors	  was	  observed	  by	  using	  a	  solid	  growth	  assay.	  Dilutions	  of	  
yeast	   cells	   from	  overnight	   liquid	   cultures	   in	   YNB	  medium	   lacking	   in	   uracil	   and	   leucine	   (YNB-­‐UL)	  
were	   prepared	   determining	   the	   initial	   concentration	   by	   absorption	   at	   600	   nm	   (OD600	   =	   1.0	  
corresponding	  to	  ≈	  2.0x107	  cells/mL).	  During	  the	  optimization	  of	  the	  solid	  growth	  assay,	  different	  
dilutions	  were	  tested	  (OD	  =	  0.002-­‐0.2).	  1.5	  µL	  of	  the	  mentioned	  dilutions	  were	  loaded	  onto	  agar	  
plates	  containing	  a	  selective	  medium	  lacking	  in	  Leu,	  Ura	  and	  His	  (YNB-­‐ULH)	  and	  onto	  agar	  plates	  
containing	  control	  medium	  (YNB-­‐UL).	  The	  plates	  were	   incubated	  at	  30°C	  and	  scanned	  after	  24h,	  
48h	   and	  72h.	   The	   yeast	   growth	  was	  quantified	  with	  Quantity	  One	   imaging	   software	  by	  Bio-­‐Rad	  












	   14	  
3 Results	  
	  
3.1 Solid	  growth	  assay:	  first	  screen	  (GPR112-­‐7TM	  and	  GPR112-­‐GPS)	  
	  
This	  first	  screen	  of	  solid	  growth	  assays	  has	  been	  performed	  to	  optimise	  the	  further	  tests.	  GPR112-­‐
GPS	   and	   GPR112-­‐7TM	   have	   been	   chosen	   for	   this	   step	   since	   the	   high	   activity	   of	   these	   two	  
constructs	  found	  in	  HEK293	  cells	  during	  the	  previous	  study	  (figure	  7).	  	  
	  
The	   plates	   with	   YNB-­‐UL	   are	   necessary	   to	   monitor	   the	   growth	   of	   the	   samples.	   Since	   the	   MMY	  
strains	   are	   able	   to	   produce	   leucine	   (Leu)	   while	   the	   p426GPD	   has	   the	   information	   to	   produce	  
uracile	  (Ura),	  only	  the	  yeast	  cells	  successfully	  transformed	  can	  grow	  up	  on	  this	  medium.	  Moreover,	  
they	  are	  useful	  to	  compare	  the	  growth	  of	  the	  samples	  with	  the	  one	  of	  the	  empty	  vector	  because	  
the	   non-­‐yeast	   GPCRs	   can	   have	   toxic	   effects	   on	   the	   host.	   The	   plates	  with	   the	   selective	  medium	  
(YNB-­‐ULH),	   give	   information	  about	   the	  activation	  of	   the	   receptor.	   The	  production	  of	  histidine	   is	  
correlated	   with	   the	   activation	   of	   the	   GPCR	   expressed	   in	   the	   cells;	   if	   the	   receptor	   under	  
consideration	  does	  not	  couple	  via	  that	  Gα	  subunit,	  the	  biosynthesises	  of	  His	  cannot	  occur	  and	  the	  
yeast	  cannot	  grow	  up.	  
Tests	  have	  been	  performed	  in	  quintuple.	  For	  the	  first	  screen	  the	  results	  have	  been	  gathered	  after	  
48h	  while	  for	  the	  second	  part	  of	  the	  study	  72	  hours	  because	  the	  differences	  in	  growth	  where	  more	  
appreciable	  than	  after	  48h.	  
	  
Toxicity	  slightly	  affected	  the	  growth	  of	  the	  yeast	  cells	  hosting	  the	  two	  constructs	   in	  the	  MMY28,	  
MMY25,	  MMY23	  and	  MMY22	  (figure	  10)	  while	  it	  had	  a	  remarkable	  effect	  on	  the	  MMY21,	  MMY20	  
and	  MMY24	   (figure	  11).	   This	  phenomenon	   can	  be	  noticed	  on	   the	  bar	   graphs	  about	   the	  YNB-­‐UL	  
plates.	   In	   that	  case,	   the	  bar	  of	   the	  plasmid	   is	  higher	   than	   the	  bars	  of	   the	  constructs	   in	   fact,	   the	  
toxicity	  of	  some	  receptors	  can	  cause	  a	  decrease	  of	  the	  rate	  of	  growth	  of	  the	  yeast	  cells	  (Dowell	  et	  
al.	  2009).	  Comparing	  the	  growth	  of	  the	  constructs	  in	  a	  certain	  strain	  with	  the	  empty	  vector	  in	  the	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Fig.10	  Strains	  in	  which	  the	  heterologous	  GPCRs	  determined	  a	  slight	  toxicity	  (n=1	  performed	  in	  quintuple).	  There	  is	  a	  
slightly	  lower	  density	  of	  cells	  of	  GPR112-­‐7TM	  and	  GPS	  than	  the	  empty	  plasmid.	  This	  is	  visible	  in	  all	  the	  concentrations	  






Fig.	  11	  Strains	  in	  which	  the	  heterologous	  GPCRs	  determined	  a	  remarkable	  toxicity	  (n=1	  performed	  in	  quintuple).	  There	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This	  phenomenon	  could	  interfere	  with	  the	  level	  of	  activation	  on	  the	  plates	  with	  YNB-­‐ULH.	  In	  fact,	  
in	  the	  MMY28	  the	  empty	  vector	  shows	  higher	  levels	  than	  the	  constructs	  and	  the	  same	  happened	  





Fig.	  12	  Effects	  of	  toxicity	  on	  the	  growth	  on	  the	  plates	  with	  the	  selective	  medium	  (n=1	  performed	  in	  quintuple).	  The	  
constructs	  show	  a	  lower	  activation	  than	  the	  empty	  plasmid	  in	  all	  the	  concentrations	  tested.	  
	  
On	  the	  contrary,	  in	  the	  MMY21	  the	  constructs	  show	  significant	  difficulties	  compare	  to	  the	  empty	  
p426GPD	  but	  examining	  the	  plates	  with	  YNB-­‐ULH,	  the	  GPR112-­‐7TM	  displays	  an	  impressive	  growth	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Fig.	   13	  Constitutive	  activity	  of	   the	  GPR112-­‐7TM	  (n=1	  performed	   in	  quintuple).	  The	  GPR112-­‐7TM	  shows	  constitutive	  
activity	  in	  this	  strain.	  
	  
Good	  levels	  of	  activation	  have	  been	  reached	  also	   in	  MMY19	  and	  MMY16;	  GPR112-­‐7TM	  and	  GPS	  
are	  about	  at	  the	  same	  level	  in	  the	  MMY19	  while	  in	  the	  MMY16	  the	  GPR112-­‐7TM	  is	  higher	  than	  the	  
GPR112-­‐GPS	  (figure	  14).	  
	  
	  
Fig.	   14	   Constitutive	   activity	   of	   the	   receptors	   in	   MMY19	   on	   the	   left	   and	   MMY16	   on	   the	   right	   (n=1	   performed	   in	  
quintuple).	  
	  
The	  GPR112-­‐7TM	  and	  GPR112-­‐GPS	  did	  not	  show	  any	  level	  of	  activation	  in	  just	  one	  strain,	  the	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Fig.15	  No	  activation	  of	  the	  receptors	  in	  the	  MMY14	  (left)	  and	  just	  a	  very	  low	  level	  in	  the	  MMY24	  at	  the	  highest	  




Fig.	  16	  Results	  obtained	  with	  GPR112-­‐7TM	  and	  –GPS.	  The	  two	  receptor	  transformed	  into	  the	  strain	  highlighted	  in	  red	  
did	   not	   show	   any	   kind	   of	   activity.	   The	   strains	   highlighted	   in	   yellow	   showed	   a	   slight	   level	   of	   activation	   of	   the	   two	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3.2 Solid	  growth	  assay:	  constructs	  
	  
In	   the	   second	   part	   of	   the	   study,	   the	   solid	   growth	   assays	   have	   been	   performed	   with	   all	   the	  
constructs	   transformed	   in	   four	   different	   strains:	   MMY21,	   MMY16,	   MMY19	   and	   MMY20.	   The	  
results	  have	  been	  obtained	  after	  three	  independent	  assays	  performed	  in	  duplo,	  triplo	  or	  quintuple.	  
The	   plates	   have	   been	   scanned	   after	   72h.	   The	   bar	   graphs	   are	   shown	   as	   means	   ±	   SEM	   of	   ≥	   5	  
independent	  experiments,	  each	  performed	  in	  duple	  or	  triple.	  
	  
MMY21:	  chimeric	  Gpa1/Gα14	  
	  
The	  very	  high	   constitutive	  activity	  of	   the	  GPR112-­‐7TM	  noticed	  during	   the	   first	   set	  of	   assays	  has	  
been	  confirmed.	  The	  GPR112-­‐GPS	  is	  the	  only	  constructs	  that	  does	  not	  show	  any	  kind	  of	  activation.	  
Interesting	   the	   GPR112-­‐GAIN	   couples	   via	   the	   G14	   but	   considerably	   less	   (11.759	   ±	   6.189)	   than	  
GPR112-­‐7TM.	   Some	   constructs	  derived	   from	   the	  GPR64	  also	  display	   a	  high	   constitutive	   activity;	  
noteworthy	  is	  the	  result	  of	  the	  GPR64-­‐ZO1	  (69.168	  ±	  4.846).	  Also	  the	  four	  constructs	  of	  the	  GPR56	  




Fig.	  17	  Normalized	  data	  of	  the	  constructs	  transformed	  into	  the	  MMY21	  (Gα14).	  Blank	  (medium)	  has	  been	  taken	  as	  0%	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MMY16:	  chimeric	  Gpa1/Gα16	  
	  
All	   the	   constructs	   transformed	   in	   this	   strain	   have	   been	   showed	   slight	   differences	   of	   level	   of	  




Fig.	  18	  Normalized	  data	  of	  the	  constructs	  transformed	  into	  the	  MMY16.	  Empty	  p426GPD	  has	  been	  taken	  as	  0%	  while	  
GPR112-­‐7TM	  has	  been	  taken	  as	  100%	  (n=5	  performed	  in	  triple).	  
	  
MMY19:	  chimeric	  Gpa1/Gα12	  
	  
A	  very	  interesting	  outcome	  in	  this	  strain	  concerns	  the	  GPR56.	  The	  GPR56-­‐7TM	  shows	  a	  significant	  
higher	  activation	  than	  the	  others	  constructs	  derived	  from	  the	  GPR56	  (GPR56-­‐WT	  81.277	  ±	  8.982,	  
GPR56-­‐GAIN	   60.925	   ±	   5.273,	   GPR56-­‐GPS	   47.264	   ±	   5.273,	   GPR56-­‐7TM	   166.799	   ±	   44.205).	  
Significant	  is	  also	  the	  result	  of	  the	  GPR64-­‐WT	  (156.923	  ±	  30.482)	  and	  GPS	  (225.851	  ±	  54.470)	  while	  
in	  this	  assay	  the	  ZO1	  is	  the	  lowest	  one	  among	  the	  GPR64	  constructs	  (47.825	  ±	  8.440)	  	  (figure	  19).	  
	  
	  
Fig.	  19	  Normalized	  data	  of	  the	  constructs	  transformed	  into	  the	  MMY19.	  Empty	  p426GPD	  has	  been	  taken	  as	  0%	  while	  
GPR112-­‐7TM	  has	  been	  taken	  as	  100%	  (n=3	  performed	  in	  duple).	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MMY20:	  chimeric	  Gpa1/Gα13	  
	  
As	  in	  the	  first	  set,	  the	  empty	  vector	  has	  a	  higher	  growth	  than	  the	  constructs.	  Also	  in	  this	  assay,	  the	  
GPR56-­‐7TM	   displays	   the	   best	   outcome	   among	   the	   others	   GPR56	   (GPR56-­‐WT	   51.892	   ±	   3.220,	  
GPR56-­‐GAIN	  31.295	  ±	  0.721,	  GPR56-­‐GPS	  29.388	  ±	  2.519,	  GPR56-­‐7TM	  98.975	  ±	  3.023)	  and	  also	  the	  
other	  two	  aGPCRs.	  There	  are	  not	  significant	  differences	  between	  the	  GPR112-­‐GAIN,	  GPR112-­‐GPS	  
and	  GPR112-­‐7TM	  (74.951	  ±	  10.116,	  91.609	  ±	  4.659,	  96.736	  ±	  2.445	  respectively)	  while	  about	  the	  
GPR64,	  the	  ZO1	  (97.733	  ±	  24.509)	  and	  the	  GPS	  (81.497	  ±	  4.515)	  are	  slightly	  higher	  than	  the	  others	  




Fig.	  20	  Normalized	  data	  of	  the	  constructs	  transformed	  into	  the	  MMY20.	  Blank	  (medium)	  has	  been	  taken	  as	  0%	  while	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4 Discussions	  and	  conclusions	  
	  
The	  aim	  of	  this	  study	  was	  to	  shed	  light	  on	  the	  downstream	  pathways	  involved	  in	  the	  activation	  of	  
three	  different	  aGPCRs	  by	  using	  S.	  cerevisiae.	  Since	  the	  majority	  of	  the	  aGPCRs	  is	  still	  orphans,	  the	  
constitutive	   activity	   of	   these	   receptors	   has	   been	   investigated	   to	   gather	   information	   about	   the	  
signaling-­‐transduction	  pathways.	  
	  
All	   the	   constructs	   except	   the	   GPR112-­‐HormB	   have	   been	   successfully	   transformed	   into	   several	  
yeast	   strains.	   The	   difficulties	   found	   to	   clone	   the	   GPR112-­‐HormB	   can	   be	   due	   to	   the	   size	   of	   the	  
receptor	  (appendix,	  table	  B).	  
	  
From	  the	  first	  screen	  emerges	  the	  incredibly	  activation	  of	  the	  GPR112-­‐7TM,	  intriguingly	  high	  in	  the	  
MMY21	   (via	  Gα14	  a	   subtype	  of	  Gαq)	  but	  null	   in	   the	  MMY14	   (via	  Gαq).	   This	  outcome	  highlights	  
how	  sensitive	  the	  receptor	  is	  about	  the	  coupling.	  
Another	  interesting	  result	  about	  the	  GPR112	  transformed	  into	  the	  MMY21	  that	  comes	  out	  is	  that	  
the	  7TM	  truncation	  shows	  the	  highest	  activity,	  the	  GPS	  null	  and	  the	  GAIN	  displays	  a	  slight	  activity	  
(100,001	  ±	  0.001,	   -­‐1.357	  ±	  1.839,	  11.759	  ±	  6.189	  respectively,	   figure	  17).	  This	  phenomenon	   is	   in	  
accord	  with	  Araç’s	  article	  (Araç	  et	  al.	  2012)	  in	  which	  the	  author	  suggested	  that	  the	  GAIN	  domain	  is	  
necessary	   for	   the	   autoproteolysis	  while	   the	   only	   GPS	  motif	   is	   not	   enough	   to	   cleave	   out	   the	  N-­‐
terminus.	  Looking	  at	  the	  figure	  4,	  the	  mechanism	  of	  activation	  of	  the	  GAIN	  domain	  found	  with	  the	  
GPR112	  via	  Gα14	  can	  be	  describe	  as	  something	  between	  the	  cartoon	  4A	  and	  4B;	  in	  the	  cartoon	  4A	  
the	   GAIN	   domain	   acts	   as	   a	   negative	   regulator	   and	   after	   the	   cleavage	   of	   the	   N-­‐terminus	   the	  
receptor	  is	  activated	  while	  in	  the	  cartoon	  4B	  the	  cleavage	  of	  the	  N-­‐terminus	  interrupts	  the	  signal.	  
From	   the	   assay,	   the	   GPR112-­‐GAIN	   in	   the	   MMY21	   strain	   cannot	   be	   considered	   as	   a	   negative	  
regulator	  since	   it	  does	  not	  block	  totally	  the	  response	  but	  neither	  as	  a	  positive	  regulator,	  since	   it	  
modulates	   in	   a	   negative	   way	   the	   full	   activity	   of	   the	   receptor	   found	   with	   the	   GPR112-­‐7TM.	  
Although	  the	  GAIN	  domain	  seems	  to	  regulate	   the	  activity	  of	   this	   receptor	  via	   the	  Gα14	  subunit,	  
this	  modulation	  does	  not	  occur	  via	  the	  other	  tested	  strains	  (figures	  18,	  19	  and	  20).	  
The	  discrepancy	  between	  this	  result	  and	  the	  one	  found	  in	  the	  HEK293	  cells	  during	  the	  preliminary	  
studies,	   in	  which	   the	   level	   of	   activation	   of	   the	  GPR112-­‐GAIN	   is	   null	   and	   the	  GPR112-­‐GPS	   slight	  
(figure	  7),	  might	  be	  explained	  with	  the	  differences	  between	  yeast	  and	  mammalian	  cell	  membrane.	  
As	  explained,	  yeast	  can	  be	  used	  because	  of	  the	  similarities	  between	  the	  mammalian	  and	  the	  yeast	  
G	  proteins.	  The	  highest	  homology	  has	  been	  found	  with	  the	  Gαi	  (48%	  identity,	  65%	  similarity)	  and	  
the	  lowest	  with	  the	  Gαs	  (33%	  identity,	  51%	  similarity)	  (Miyajima	  et	  al.	  1987;	  Dowell	  et	  al.	  2002).	  
However,	  there	  are	  differences	  that	  can	  alter	  the	  results	  or	  make	  them	  not	  comparable	  with	  the	  
mammalian	  cells.	  For	  instance	  the	  amount	  of	  N-­‐glycans	  in	  the	  oligosaccharide	  structures	  of	  yeast	  
is	   different	   from	   the	   mammalian	   one,	   moreover	   the	   lipid	   composition	   changes	   and	   yeast	  
synthesises	  ergosterol	   rather	   than	  cholesterol.	  Furthermore	  the	  expression	  of	  a	   receptor	  can	  be	  
difficult.	   If	   the	  host	   environment	   is	   close	   to	   the	  native	   environment	   there	   are	  more	   chances	   to	  
achieve	   this	   goal.	   These	   differences	   can	   be	   relevant	   if	   the	   functionality	   of	   the	   GPCRs	   under	  
consideration	  is	  connected	  to	  this	  structure	  (Sarregna	  et	  al.	  2003).	  
	  
The	  promiscuity	  of	  the	  Gα16	  can	  explain	  the	  result	  obtained	  with	  the	  MMY16.	  Gα16	  recognizes	  	  	  a	  
multitude	  of	  GPCRs	  usually	  coupled	  to	  Gαi	  or	  Gαs	  and	  it	  is	  considered	  as	  a	  “universal	  adapter”	  for	  
GPCRs	   (Liu	   et	   al.	   2003,	   New	   et	   al.	   2005).	   The	   result	   with	   this	   strain	   does	   not	   give	   further	  
information	  about	  the	  differences	  among	  the	  different	  truncations	  of	  these	  receptors,	  since	  all	  the	  
constructs	  show	  about	  the	  same	  level	  of	  activation.	  Although	  the	  Gα16	  is	  more	  promiscuous	  than	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other	  G	  proteins,	  it	  does	  not	  mean	  that	  all	  the	  GPCRs	  couple	  via	  that	  signaling	  pathway	  (Mody	  et	  
al.	  1999).	  Preliminary	  data	  showed	  that	  the	  expression	  of	  the	  HCA3	  receptor	  in	  this	  strain	  did	  not	  
evoke	  a	  response	  even	  in	  presence	  of	  a	  ligand	  (data	  not	  shown).	  
	  
The	   MMY19	   and	   MMY20	   have	   been	   chosen	   for	   the	   second	   part	   of	   assays	   because	   of	   the	  
significant	  activity	  showed	  during	  the	  first	  screen	  with	  the	  GPR112-­‐7TM	  and	  GPR112-­‐GPS	  (figures	  
12	  and	  14).	  Moreover,	  it	  has	  been	  found	  in	  literature	  that	  the	  GPR56	  couples	  via	  Gα12	  and	  Gα13.	  
Genetic	   studies	   revealed	   collagen	   III	   as	   the	   endogenous	   ligand	  of	   the	  GPR56.	   Its	   binding	   to	   the	  
receptor	   activates	   RhoA	   via	   coupling	   to	   Gα12/13	   (Iguchi	   et	   al.	   2008;	   Luo	   et	   al.	   2011).	   This	   is	  
compatible	  with	  the	  outcome	  obtained	  from	  the	  two	  assays.	  It	  is	  interesting	  how	  in	  both	  of	  them	  
the	   GPR56-­‐7TM	   displays	   the	   highest	   activity:	   GPR56-­‐WT	   81.277	   ±	   8.982,	   GPR56-­‐GAIN	   60.925	   ±	  
5.273,	   GPR56-­‐GPS	   47.264	   ±	   5.273,	   GPR56-­‐7TM	   166.799	   ±	   44.205in	   the	  MMY19	   and	  GPR56-­‐WT	  
51.892	   ±	   3.220,	   GPR56-­‐GAIN	   31.295	   ±	   0.721,	   GPR56-­‐GPS	   29.388	   ±	   2.519,	   GPR56-­‐7TM	   98.975	   ±	  
3.023	  in	  MMY20.	  Although	  it	  is	  a	  bit	  difficult	  to	  analyse	  the	  outcome	  obtained	  with	  MMY20	  since	  
the	  toxicity	  of	  the	  receptors	  and	  the	  high	  constitutive	  activity	  of	  the	  empty	  plasmid	  in	  this	  strain.	  
The	  higher	  activity	  of	  the	  7TM	  truncations	  agrees	  with	  the	  mechanism	  suggested	  by	  Paavola	  et	  al.	  
who	  demonstrated	  that	  the	  truncation	  of	  the	  N-­‐terminus	  in	  the	  GPR56	  enhances	  the	  constitutive	  
activity	   of	   receptor	   signaling	   (Paavola	   et	   al.	   2013).	   It	   has	   to	   be	  mentioned	   that	   also	   the	   other	  
truncations	  of	  the	  GPR56	  show	  a	  slight	  response	  but	  with	  the	  N-­‐terminus	  that	  modulates	  the	  level	  
of	  activation	  as	  noticed	  with	  the	  GPR112	  in	  the	  MMY21	  (figure	  17).	  
	  
The	  results	  about	  the	  GPR64	  obtained	  from	  all	  the	  strains	  highlighted	  the	  response	  of	  the	  GPR64-­‐
ZO1,	  which	   is	   interestingly	  higher	  than	  the	  other	  truncations	  of	  this	  receptor	   in	  the	  MMY21	  and	  
MMY20	   (69.168	   ±	   4.846	   and	   97.733	   ±	   24.509	   respectively)	   but	   it	   showed	   the	   lowest	   activity	  
among	  the	  GPR64	  constructs	  in	  the	  MMY19	  (47.825	  ±	  8.440).	  An	  explanation	  for	  this	  phenomenon	  
is	  that	  this	  domain	  might	  has	  intramolecular	  interactions	  with	  other	  components	  of	  the	  ECD	  as	  it	  
hypotheses	  for	  the	  GAIN	  domain	  in	  the	  figure	  4C.	  The	  ZO-­‐1	  domain	  belongs	  to	  the	  PDZ	  domains,	  
which	  are	   characterized	  by	   the	  binding	   to	   short	  amino	  acids	  motifs	  on	   the	  C-­‐terminus	  of	   target	  
proteins	  (Ponting	  et	  al.	  1997).	  
	  
From	   this	   study	   emerges	   that	   the	   three	   receptors,	   that	   all	   belong	   to	   the	   subfamily	   VIII	   of	   the	  
aGPCRs,	  have	  a	  different	  mechanism	  of	  activation.	  In	  fact,	  the	  GPR64-­‐ZO1	  seems	  to	  interact	  with	  
other	   components	   on	   the	   extracellular	   region	   via	   Gα14	   (figure	   17)	   and	   Gα12	   (figure	   19),	   the	  
GPR56	  shows	  a	  higher	  activity	  when	  the	  N-­‐terminal	  fragment	  is	  cleaved	  out	  via	  Gα12	  (figure	  19)	  
and	  Gα13	  (figure	  20)	  and	  the	  GPR112-­‐GAIN	  modulates	  the	  activity	  of	  the	  receptor	  via	  Gα14,	  which	  
is	  fully	  activated	  when	  the	  N-­‐terminus	  is	  removed	  (figure	  17).	  
Furthermore,	   the	   signaling	   pathway	   involved	   can	   affect	   the	   response	   of	   a	   receptor	   in	   fact,	   the	  
GPR64-­‐ZO1	  modulates	  the	  activity	  of	  the	  receptor	  positively	  in	  the	  MMY21	  (Gα14)	  but	  negatively	  
in	  the	  MMY19	  (Gα12),	  the	  three	  constructs	  of	  the	  GPR112	  show	  the	  same	  level	  of	  activation	  in	  the	  
MMY16	   (Gα16),	  MMY19	   (Gα12)	   and	  MMY20	   (Gα13)	   while	   in	   the	  MMY21	   the	   receptor	   is	   fully	  
activated	   when	   the	   N-­‐terminus	   is	   removed.	   The	   GPR56-­‐7TM	   has	   a	   remarkable	   activity	   in	   the	  
MMY19	  and	  MMY20	  but	  it	  does	  not	  in	  the	  MMY21	  and	  MMY16.	  
These	  results	  underline	  the	  difficulties	   in	  studying	  the	  adhesion	  GPCRs	  since	   it	   is	  not	  possible	  to	  
define	  a	  general	  rule.	  Their	  mechanisms	  in	  fact	  change	  basing	  on	  the	  receptor	  under	  consideration	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5 Future	  works	  
	  
Saccharomyces	  cerevisiae	  is	  a	  powerful	  and	  affordable	  tool	  to	  investigate	  aGPCRs.	  For	  the	  future,	  
it	  might	  be	  interesting	  test	  all	  the	  constructs	  in	  other	  strains	  in	  order	  to	  obtain	  more	  information	  
about	  the	  coupling.	  Liquid	  growth	  assays	  might	  be	  performed	  in	  absence	  of	  ligand	  but	  it	  could	  be	  
possible	   compare	   those	   results	  with	   results	   gained	   from	  known	   receptors	  with	   a	   known	   ligand.	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8 Appendix	  
	  
Tab.	  A	  Genotypes	  of	  the	  strains	  used	  (adapted	  from	  Dowell	  et	  al.	  2009)	  
	  
Strain	   Genotype	   C-­‐terminal	   amino	   acids	   of	   Gα	  
subunits	  
MMY11	   MATahis3	  ade2leu2	  trp1	  ura3can1fus1::	  FUS1-­‐HIS3FUS1-­‐lacZ::LEU2	  
far∆::ura3∆gpa1∆::ADE2∆sst2∆	  ::ura3∆ste2∆::G418R	  
	  
MMY14	   MMY11	  TRP1::Gpa1/Gαq	   EYNLVCOOH	  
MMY16	   MMY11	  TRP1::Gpa1/Gα16	   EYNLVCOOH	  
MMY19	   MMY11	  TRP1::Gpa1/Gα12	   DIMLQCOOH	  
MMY20	   MMY11	  TRP1::Gpa1/Gα13	   QLMLQCOOH	  
MMY21	   MMY11	  TRP1::Gpa1/Gα14	   EFNLVCOOH	  
MMY22	   MMY11	  TRP1::Gpa1/Gαo	   GCGLYCOOH	  
MMY23	   MMY11	  TRP1::Gpa1/Gαi1	   DCGLFCOOH	  
MMY24	   MMY11	  TRP1::Gpa1/Gαi3	   ECGLYCOOH	  
MMY25	   MMY11	  TRP1::Gpa1/Gαz	   YIGLCCOOH	  
MMY28	   MMY11	  TRP1::Gpa1/Gαs	   QYELLCOOH	  
	  
	  
Tab.	  B	  Size	  of	  the	  constructs	  
	  
Construct	   Size	  
GPR56-­‐WT	   2.081	  kb	  
GPR56-­‐GAIN	   1.705	  kb	  
GPR56-­‐GPS	   1.057	  kb	  
GPR56-­‐7TM	   0.873	  kb	  
GPR64-­‐WT	   3.054	  kb	  
GPR64-­‐ZO1	   2.708	  kb	  
GPR64-­‐GAIN	   2.036	  kb	  
GPR64-­‐GPS	   1.360	  kb	  
GPR64-­‐7TM	   1.171	  kb	  
GPR112-­‐HormB	   2.039	  kb	  
GPR112-­‐GAIN	   1.804	  kb	  
GPR112-­‐GPS	   1.162	  kb	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Fig.	  2	  Scans	  of	  some	  plates	  of	  the	  first	  set	  of	  assays.	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